Search Results

Site Search

December 2023 - Cardiovascular and Infectious Diseases - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case’s sub-specialties are Cardiovascular Pathology and Infectious Diseases Pathology.

Patients with Blood Cancer Precursor at Risk of Developing Cancer Even after 30 Years - Insights

Patients with monoclonal gammopathy of undetermined significance are at risk of progressing to multiple myeloma or a related cancer─even after 30 years of stability, according to findings of a study by Mayo Clinic researchers published in...

Monogenic IBD - Insights

A worldwide increase of the incidence of early-onset pediatric inflammatory bowel disease means more children than ever are diagnosed and treated for life-altering IBD diagnoses. However, not all children suspected of early-onset IBD have...

Malabsorption panel - Insights

Mayo Clinic Laboratories, which is integrated with the clinical gastroenterology practice at Mayo Clinic, understands the worry patients and their loved ones feel while awaiting test results. To expedite and streamline the diagnostic...

New tests launched in November - Insights

Mayo Clinic Laboratories launched the following three tests in November.

Chromium and Cobalt Testing [Test in Focus] - Insights

Chromium and cobalt blood tests are used to monitor exposure to these elements. Both of these elements are naturally occurring and widely distributed in the environment. Previously, serum samples were collected and used to monitor patients...

Case Studies in Laboratory Safety - Insights

PACEThis webinar will provide a review of several real-life laboratory safety events. The presentation will outline the scenarios, the lessons learned and look at ways future incidents can be prevented. We will also discuss ways to create...

Single-gene assays - Insights

Find out how patients with a cancer diagnosis can benefit from single-gene analysis to pinpoint whether the cancer is genetic in nature.

Mayo Clinic Laboratories releases new, first-to-U.S.-market pregnancy risk assessment - Insights

Mayo Clinic Laboratories now offers the first preeclampsia-specific test (Mayo ID: PERA) that can be used to stratify patients into low or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe...

Labor Day Holiday Shipment Schedules - Insights

Due to the Labor Day holiday (recognized on Monday, September 4th), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure specimen viability and avoid turnaround time delays, follow the guidelines...